Edition:
United States

Pfizer Inc (PFE)

PFE on New York Consolidated

33.92USD
28 Apr 2017
Change (% chg)

$0.06 (+0.18%)
Prev Close
$33.86
Open
$33.88
Day's High
$33.94
Day's Low
$33.75
Volume
15,979,173
Avg. Vol
23,160,413
52-wk High
$37.39
52-wk Low
$29.83

PFE

Chart for PFE

About

Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development and manufacture of healthcare products. Its global portfolio includes medicines and vaccines, as well as consumer healthcare products. The Company manages its commercial operations through two business... (more)

Overall

Beta: 0.97
Market Cap(Mil.): $201,997.91
Shares Outstanding(Mil.): 5,955.13
Dividend: 0.32
Yield (%): 3.77

Financials

  PFE Industry Sector
P/E (TTM): 29.09 29.18 30.12
EPS (TTM): 1.17 -- --
ROI: 5.20 13.76 13.28
ROE: 11.58 14.71 14.44

BRIEF-Pfizer Inc declared a 32-cent Q2 2017 dividend on co's common stock

* Declared a 32-cent second-quarter 2017 dividend on company's common stock Source text for Eikon: Further company coverage:

Apr 27 2017

BRIEF-InSphero announces agreement with Pfizer to develop novel assays for predicting drug-induced liver injury

* Insphero announces agreement with Pfizer to develop novel assays for predicting drug-induced liver injury

Apr 27 2017

BRIEF-Aquinnah receives $10 mln investment from Pfizer, Abbvie

* Aquinnah Pharmaceuticals receives $10 million investment from Pfizer and Abbvie to research breakthrough approach to neurodegenerative disease

Apr 25 2017

BRIEF-EU Medicines Agency recommendations for April 2017

* EU Medicines Agency recommends approval granting of a marketing authorisation for Sandoz's Rixathon Non-Hodgkin's Lymphoma (NHL), chronic lymphocytic leukaemia

Apr 21 2017

UPDATE 3-Pfizer subpoenaed in U.S. intravenous saline solution probe

BOSTON, April 19 Pfizer Inc has received grand jury subpoenas from the U.S. Justice Department in connection with an antitrust investigation focusing on drugmakers that market intravenous saline solutions.

Apr 19 2017

Pfizer receives subpoenas in U.S. intravenous saline solution probe

BOSTON Pfizer Inc said on Wednesday that the company had received grand jury subpoenas from the U.S. Justice Department amid an antitrust investigation focused on drugmakers that market intravenous saline solution.

Apr 19 2017

Pfizer subpoenaed in U.S. intravenous saline solution probe

BOSTON Pfizer Inc has received grand jury subpoenas from the U.S. Justice Department in connection with an antitrust investigation focusing on drugmakers that market intravenous saline solutions.

Apr 19 2017

Pfizer receives subpoenas in U.S. intravenous saline solution probe

BOSTON, April 19 Pfizer Inc said on Wednesday that the company had received grand jury subpoenas from the U.S. Justice Department amid an antitrust investigation focused on drugmakers that market intravenous saline solution.

Apr 19 2017

BRIEF-Hitgen, Pfizer enter research collaboration and license agreement to build and screen novel DNA-encoded libraries

* Hitgen and Pfizer enter research collaboration and license agreement to build and screen novel dna-encoded libraries

Apr 18 2017

Factbox: Main hurdle to death by lethal injection - the drug industry

A federal judge in Arkansas has blocked plans by the state to carry out a rapid series of executions, questioning the state's use of midazolam, one of the drugs it planned to use for lethal injection.

Apr 17 2017

More From Around the Web

Competitors

  Price Chg
Johnson & Johnson (JNJ.N) $123.47 -0.27
Novartis AG (NOVN.S) CHF76.55 -0.35
Merck & Co., Inc. (MRK.N) $62.33 -0.25
Roche Holding Ltd. (ROG.S) CHF260.30 0.00
Roche Holding Ltd. (RO.S) CHF260.50 -1.00
Abbott Laboratories (ABT.N) $43.64 -0.01
Bayer AG (BAYGn.DE) €113.60 +0.95
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €86.61 +0.64
AstraZeneca plc (AZN.L) 4,637.50 -60.50

Earnings vs. Estimates